Literature DB >> 33990198

Translation of oncology multidisciplinary team meeting (MDM) recommendations into clinical practice.

Shalini K Vinod1,2,3, Nisali T Wellege4, Sara Kim4, Kirsten J Duggan5,6, Mirette Ibrahim7, Jesmin Shafiq4,5.   

Abstract

BACKGROUND: Multidisciplinary team meeting (MDM) processes differ according to clinical setting and tumour site. This can impact on decision making. This study aimed to evaluate the translation of MDM recommendations into clinical practice across solid tumour MDMs at an academic centre.
METHODS: A retrospective audit of oncology records was performed for nine oncology MDMs held at Liverpool Hospital, NSW, Australia from 1/2/17-31/7/17. Information was collected on patient factors (age, gender, country of birth, language, postcode, performance status, comorbidities), tumour factors (diagnosis, stage) and MDM factors (number of MDMs, MDM recommendation). Management was audited up to a year post MDM to record management and identify reasons if discordant with MDM recommendations. Univariate and multivariable regression analyses were performed to assess for factors associated with concordant management.
RESULTS: Eight hundred thirty-five patients were discussed, median age was 65 years and 51.4% were males. 70.8% of patients were presented at first diagnosis, 77% discussed once and treatment recommended in 73.2%. Of 771 patients assessable for concordance, management was fully concordant in 79.4%, partially concordant in 12.8% and discordant in 7.8%. Concordance varied from 84.5% for lung MDM to 97.6% for breast MDMs. On multivariable analysis, breast and upper GI MDMs and discussion at multiple MDMs were significantly associated with concordant management. The most common reason for discordant management was patient/guardian decision (28.3%).
CONCLUSION: There was variability in translation of MDM recommendations into clinical practice by tumour site. Routine measurement of implementation of MDM recommendations should be considered as a quality indicator of MDM practice.

Entities:  

Keywords:  Decision making; Health care quality indicator; Health services research; Hospital oncology service; Patient care team

Year:  2021        PMID: 33990198     DOI: 10.1186/s12913-021-06511-3

Source DB:  PubMed          Journal:  BMC Health Serv Res        ISSN: 1472-6963            Impact factor:   2.655


  23 in total

Review 1.  Quality of care management decisions by multidisciplinary cancer teams: a systematic review.

Authors:  Benjamin W Lamb; Katrina F Brown; Kamal Nagpal; Charles Vincent; James S A Green; Nick Sevdalis
Journal:  Ann Surg Oncol       Date:  2011-03-26       Impact factor: 5.344

2.  Do multidisciplinary meetings follow guideline-based care?

Authors:  Shalini K Vinod; Mark A Sidhom; Geoff P Delaney
Journal:  J Oncol Pract       Date:  2010-11       Impact factor: 3.840

Review 3.  Is it worth reorganising cancer services on the basis of multidisciplinary teams (MDTs)? A systematic review of the objectives and organisation of MDTs and their impact on patient outcomes.

Authors:  Joan Prades; Eline Remue; Elke van Hoof; Josep M Borras
Journal:  Health Policy       Date:  2014-09-18       Impact factor: 2.980

4.  Head and neck multidisciplinary team meetings: Effect on patient management.

Authors:  Markus Brunner; Sinclair M Gore; Rebecca L Read; Ashlin Alexander; Ankur Mehta; Michael Elliot; Chris Milross; Michael Boyer; Jonathan R Clark
Journal:  Head Neck       Date:  2014-07-11       Impact factor: 3.147

5.  Multidisciplinary team meetings in Oncology: first analysis of benefits and evaluation of activity in a Dermatology unit in France.

Authors:  Anne Caudron; Guillaume Chaby; Ali Dadban; Claire Andrejak; Florie Dhaille; Martine Bagot; Catherine Lok
Journal:  Eur J Dermatol       Date:  2010-10-20       Impact factor: 3.328

6.  Utility of a multidisciplinary tumor board in the management of pancreatic and upper gastrointestinal diseases: an observational study.

Authors:  David G Brauer; Matthew S Strand; Dominic E Sanford; Vladimir M Kushnir; Kian-Huat Lim; Daniel K Mullady; Benjamin R Tan; Andrea Wang-Gillam; Ashley E Morton; Marianna B Ruzinova; Parag J Parikh; Vamsi R Narra; Kathryn J Fowler; Majella B Doyle; William C Chapman; Steven S Strasberg; William G Hawkins; Ryan C Fields
Journal:  HPB (Oxford)       Date:  2016-12-01       Impact factor: 3.647

7.  Thoracic multidisciplinary tumor board routinely impacts therapeutic plans in patients with lung and esophageal cancer: a prospective cohort study.

Authors:  Henner M Schmidt; John M Roberts; Artur M Bodnar; Sonia Kunz; Steven H Kirtland; Richard P Koehler; Michal Hubka; Donald E Low
Journal:  Ann Thorac Surg       Date:  2015-02-10       Impact factor: 4.330

8.  Do multidisciplinary team meetings make a difference in the management of lung cancer?

Authors:  Miriam M Boxer; Shalini K Vinod; Jesmin Shafiq; Kirsten J Duggan
Journal:  Cancer       Date:  2011-04-26       Impact factor: 6.860

9.  Uro-oncology multidisciplinary meetings at an Australian tertiary referral centre--impact on clinical decision-making and implications for patient inclusion.

Authors:  Kenny Rao; Kiran Manya; Arun Azad; Nathan Lawrentschuk; Damien Bolton; Ian D Davis; Shomik Sengupta
Journal:  BJU Int       Date:  2014-07-29       Impact factor: 5.588

10.  Role of a multidisciplinary team in administering radiotherapy for esophageal cancer.

Authors:  Shengguang Zhao; Weixiang Qi; Jiayi Chen
Journal:  BMC Cancer       Date:  2020-10-08       Impact factor: 4.430

View more
  1 in total

1.  Implementation rate and effects of multidisciplinary team meetings on decision making about radiotherapy: an observational study at a single Japanese institution.

Authors:  Mayumi Ichikawa; Ken Uematsu; Natsuko Yano; Masayoshi Yamada; Takashi Ono; Shohei Kawashiro; Hiroko Akamatsu; Yasuhito Hagiwara; Hiraku Sato; Kenji Nemoto
Journal:  BMC Med Inform Decis Mak       Date:  2022-04-27       Impact factor: 3.298

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.